Loading...
HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
Histone deacetylase 8 (HDAC8), a class I HDAC that modifies non-histone proteins such as p53, is highly expressed in different hematological neoplasms including a subtype of acute myeloid leukemia (AML) bearing inversion of chromosome 16 [inv(16)]. To investigate HDAC8 contribution to hematopoietic...
Na minha lista:
| Udgivet i: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7498549/ https://ncbi.nlm.nih.gov/pubmed/33015043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00844 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|